Loading
CB
Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.) Stock: price and insider trades · Canada
Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.): what insiders have been doing
Only a handful of insider records exist for Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.), the last one from 9 September 2020, too few to describe a trend. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 9 September 2020
Declarations4 total
Common SharesTSXSEDI:3599888
Common SharesTSXSEDI:3599890
10,000 shares@ CA$0.01Common SharesTSXSEDI:3599033
Common SharesTSXSEDI:3599032
4 of 4 declarations
About Canam Biotech Inc.(formerly HemaGenetics Technologies Corp.)
Canam Biotech Inc. is a company focused on developing biopharmaceutical solutions. Formerly known as HemaGenetics Technologies Corp., it is listed on the XTSE.
